1. Healthcare Resource Utilization and Economic Burden of Prurigo Nodularis in the United States
- Author
-
Shawn G. Kwatra, Ashis K. Das, Eunice Chang, Caleb Paydar, Donia Bahloul, Chao Chen, and Ryan B. Thomas
- Subjects
Claims analysis ,Healthcare resource utilization ,Prurigo nodularis ,Dermatology ,RL1-803 - Abstract
Abstract Introduction The impacts of prurigo nodularis (PN) on healthcare resource utilization (HCRU) and associated costs are unclear. Methods This retrospective, cross-sectional claims analysis (IQVIA PharMetrics® Plus) compared HCRU and costs over 1 year in adults with PN versus matched controls (region, payer type, age, sex, year) from 2016 to 2019, and also in patients with PN receiving advanced versus localized/no therapy. For patients with data in multiple calendar years, 1 year was randomly selected. Outcomes were compared by chi-square tests, t tests, or negative binomial tests. Results We matched 16,888 patients with PN with 16,888 controls. Most comorbidities (mental health, metabolic conditions, type 2 inflammatory diseases) appeared more frequently in patients with PN versus controls. HCRU was significantly (P
- Published
- 2025
- Full Text
- View/download PDF